Moderate riskFDA DrugClass II

Amgen Sensipar cinacalcet tablets recalled for CGMP deviations

Amgen is recalling Sensipar (cinacalcet) 90mg tablets due to deviations from current good manufacturing practice (CGMP) standards. This affects one lot distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if your Sensipar matches lot #1157056 (expiration 02/29/2028).
  2. Contact your pharmacy or doctor before stopping this medication.
  3. Return the affected medication to your pharmacy or follow your doctor's instructions.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC 55513-075-30
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 5 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
1 Amgen Center Dr, N/A, Thousand Oaks, CA, United States
Classification
Class II
Recall number
D-0616-2026

In the FDA's words

Description
Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC 55513-075-30 CGMP Deviations Lot #: 1157056, Exp. Date 02/29/2028 Distribution: Nationwide within the United States Affected quantity: N/A
Hazard
CGMP Deviations

5 products in this recall

Amgen Corlanor and Sensipar tablets recalled for foreign substance

Amgen is recalling five bottle sizes of two prescription heart and thyroid-related drugs, Corlanor (ivabradine) and Sensipar (cinacalcet), because the tablets may contain a foreign substance. The products were distributed nationwide, and no injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

OtherDrugsSold nationwideMore from FDA Drug